Concert Pharmaceuticals, Inc. (CNCE): Price and Financial Metrics

Concert Pharmaceuticals, Inc. (CNCE)

Today's Latest Price: $6.15 USD

0.01 (0.16%)

Updated Oct 23 11:18am

Add CNCE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 329 in Biotech

See all "A" rated Strong Buy stocks

CNCE Stock Summary

  • CNCE's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1.1 -- higher than merely 7.33% of US-listed equities with positive expected earnings growth.
  • With a price/sales ratio of 6,316.87, Concert Pharmaceuticals Inc has a higher such ratio than 99.95% of stocks in our set.
  • As for revenue growth, note that CNCE's revenue has grown -99.98% over the past 12 months; that beats the revenue growth of just 0.54% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Concert Pharmaceuticals Inc are SAGE, VHC, TGTX, ZYNE, and NK.
  • Visit CNCE's SEC page to see the company's official filings. To visit the company's web site, go to
CNCE Daily Price Range
CNCE 52-Week Price Range

CNCE Stock Price Chart More Charts

CNCE Price/Volume Stats

Current price $6.15
Prev. close $6.14
Day low $6.09
Day high $6.24
50-day MA $8.85
200-day MA $11.44
52-week high $17.83
52-week low $5.36
Volume 46,724
Avg. volume 228,665
Dividend yield N/A
Market Cap 146.37M

Concert Pharmaceuticals, Inc. (CNCE) Company Bio

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform (deuterated chemical entity platform) to create novel small molecule drugs. The company was founded in 2006 and is based in Lexington, Massachusetts.

CNCE Latest News Stream

Event/Time News Detail
Loading, please wait...

CNCE Latest Social Stream

Loading social stream, please wait...

View Full CNCE Social Stream

CNCE Price Returns

1-mo -42.68%
3-mo -40.06%
6-mo -39.41%
1-year -58.97%
3-year -35.26%
5-year -55.37%
YTD -51.00%
2018 -51.49%
2017 151.41%
2016 -45.76%
2015 42.42%
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.551 seconds.